GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd (SHSE:600329) » Definitions » Price-to-Operating-Cash-Flow

Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Price-to-Operating-Cash-Flow : 67.88 (As of May. 15, 2024)


View and export this data going back to 2001. Start your Free Trial

What is Tianjin Pharmaceutical Da Ren Tang Group Price-to-Operating-Cash-Flow?

As of today (2024-05-15), Tianjin Pharmaceutical Da Ren Tang Group's share price is ¥36.86. Tianjin Pharmaceutical Da Ren Tang Group's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.54. Hence, Tianjin Pharmaceutical Da Ren Tang Group's Price-to-Operating-Cash-Flow Ratio for today is 67.88.

The historical rank and industry rank for Tianjin Pharmaceutical Da Ren Tang Group's Price-to-Operating-Cash-Flow or its related term are showing as below:

SHSE:600329' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 18.44   Med: 38.21   Max: 327.73
Current: 68.58

During the past 13 years, Tianjin Pharmaceutical Da Ren Tang Group's highest Price-to-Operating-Cash-Flow Ratio was 327.73. The lowest was 18.44. And the median was 38.21.

SHSE:600329's Price-to-Operating-Cash-Flow is ranked worse than
90.86% of 678 companies
in the Drug Manufacturers industry
Industry Median: 17.46 vs SHSE:600329: 68.58

Tianjin Pharmaceutical Da Ren Tang Group's Cash Flow from Operations per share for the three months ended in Mar. 2024 was ¥-0.12. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.54.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Tianjin Pharmaceutical Da Ren Tang Group was -46.20% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 0.80% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 13.80% per year.

During the past 13 years, Tianjin Pharmaceutical Da Ren Tang Group's highest 3-Year average Operating Cash Flow per Share Growth Rate was 157.70% per year. The lowest was -60.90% per year. And the median was 13.05% per year.


Tianjin Pharmaceutical Da Ren Tang Group Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Tianjin Pharmaceutical Da Ren Tang Group's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tianjin Pharmaceutical Da Ren Tang Group Price-to-Operating-Cash-Flow Chart

Tianjin Pharmaceutical Da Ren Tang Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.59 20.07 28.35 33.37 37.68

Tianjin Pharmaceutical Da Ren Tang Group Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 39.99 49.17 44.81 37.68 51.38

Competitive Comparison of Tianjin Pharmaceutical Da Ren Tang Group's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Tianjin Pharmaceutical Da Ren Tang Group's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tianjin Pharmaceutical Da Ren Tang Group's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tianjin Pharmaceutical Da Ren Tang Group's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Tianjin Pharmaceutical Da Ren Tang Group's Price-to-Operating-Cash-Flow falls into.



Tianjin Pharmaceutical Da Ren Tang Group Price-to-Operating-Cash-Flow Calculation

Tianjin Pharmaceutical Da Ren Tang Group's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=36.86/0.543
=67.88

Tianjin Pharmaceutical Da Ren Tang Group's Share Price of today is ¥36.86.
Tianjin Pharmaceutical Da Ren Tang Group's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.54.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Tianjin Pharmaceutical Da Ren Tang Group Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Tianjin Pharmaceutical Da Ren Tang Group's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Business Description

Traded in Other Exchanges
Address
No. 17 Baidi Road, Zhong Xin Mansion, Nankai District, Tianjin, CHN, 300193
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is a pharmaceutical manufacturing company. The company manufactures and sells traditional Chinese medicine, western medicine, and healthcare products in the People's Republic of China. It operates in two segments namely The Chinese Medicine segment and The Western Medicine segment. The Chinese Medicine segment manufactures Chinese pharmaceutical products under brands owned by the group. The Western Medicine segment manufactures western pharmaceutical products through cooperation with foreign companies. The company earns the majority of its revenue from the sale of Chinese pharmaceutical products.

Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Headlines

No Headlines